Publication Date:
1987-04-03
Description:
Although certain gold [Au(I)] compounds have been used effectively in the treatment of rheumatoid arthritis for some years, the molecular basis for such therapeutic action has been unclear. One possible mechanism of the action of Au(I) compounds is that they protect unsaturated membrane lipids and proteins against oxidative degradation caused by activated phagocytes that are not properly regulated. In this study it has been shown that superoxide ion (O-2.), a product of activated phagocytes, can be oxidized to electronically excited singlet oxygen (O1(2)delta g), an agent that is capable of peroxidation of unsaturated fatty acid derivatives. It has also been shown that antiarthritic Au(I) compounds are effective deactivators of O1(2)delta g with quenching constants on the order of 10(7) M-1 sec-1.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Corey, E J -- Mehrotra, M M -- Khan, A U -- New York, N.Y. -- Science. 1987 Apr 3;236(4797):68-9.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/3563489" target="_blank"〉PubMed〈/a〉
Keywords:
Arthritis, Rheumatoid/drug therapy
;
*Auranofin
;
Chemistry, Physical
;
Humans
;
Kinetics
;
Lipid Peroxides
;
*Oxygen
;
Physicochemical Phenomena
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
